May 09, 2024 01:04 (IST)
Follow us:
Applying for emergency use of Covid-19 vaccine in 2 weeks: Serum Institute
New Delhi/IBNS: The Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.
Latest Headlines
PM Modi, Mamata Banerjee, Adar Poonawalla feature in TIME's 100 most influential people's list Thu, Sep 16 2021
Hope to resolve soon: SII CEO Adar Poonawalla on Covishield-vaccinated Indians facing EU travel issues Mon, Jun 28 2021
Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses Thu, May 13 2021
My comments have been misinterpreted: Adar Poonawalla clarifies on interview with UK media Mon, May 03 2021
Aggression over Covid vaccines overwhelming, says Adar Poonawalla hinting to start producing in Britain Sat, May 01 2021
Opposition targets Modi govt over 'vaccine discrimination' after Serum Institute announces Covishield prices Thu, Apr 22 2021
Bangladesh requests India to expedite delivery of Covishield Thu, Apr 22 2021